🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine the dose, safety, radiation dosimetry and efficacy of 177Lu-rh...
Status
Recruiting
Location
Biogenix Molecular LLC
Start Date
2022-07-20
Trial ID
NCT05413850
Treatments Being Tested
PET/CT and EBV DNA are important in diagnosis of NPC. We consider that comb...
Status
Completed
Location
Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center
Start Date
2018-10-01
Trial ID
NCT03601390
Treatments Being Tested
In order to treat individuals with Down syndrome (DS) better and more effic...
Status
Completed
Location
St. Joseph's Hospital and Medical Center
Start Date
2016-11
Trial ID
NCT02759887
The main objective of this study is to make a first evaluation of the relat...
Status
Completed
Location
CHRU de Montpellier - Hôpital Gui de Chauliac
Start Date
2016-01-29
Trial ID
NCT02329626
Treatments Being Tested
The purpose of this research study is to use a relatively new technology, c...
Status
Completed
Location
University of Pittsburgh
Start Date
2005-04
Trial ID
NCT00222768
This clinical trial studies diffusion-weighted magnetic resonance imaging (...
Status
Withdrawn
Location
Virginia Commonwealth University Massey Cancer Center
Start Date
2014-07
Trial ID
NCT02059889
The purpose of this research study is to evaluate a new drug pembrolizumab ...
Status
Unknown
Location
Stanford Cancer Institute
Start Date
2017-11-09
Trial ID
NCT03226249
This phase II trial tests whether gallium-68 (Ga-68) prostate specific memb...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2024-08-12
Trial ID
NCT06521775
Treatments Being Tested
The purpose of this study is to assess whether patients who are likely to f...
Status
Unknown
Location
BC Cancer Agency
Start Date
2006-08
Trial ID
NCT00324467
After a screening phase of up to 42 days, eligible subjects will undergo tw...
Status
Unknown
Location
VUMedicalCentre
Start Date
2017-01-20
Trial ID
NCT03065764
Treatments Being Tested